PATHEON INC

Featured products of Patheon

Omjjara

Omjjara FC tab 100 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 150 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 200 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Xcopri

Xcopri tab 12.5 mg + 25 mg

cenobamate

Packing/Price

(titration pack) 28's

MIMS Class

Anticonvulsants

ATC Classification

N03AX25 - cenobamate : Belongs to the class of other antiepileptics.

Xcopri tab 50 mg

cenobamate

Packing/Price

30's

MIMS Class

Anticonvulsants

ATC Classification

N03AX25 - cenobamate : Belongs to the class of other antiepileptics.

Distributed by DCH Auriga - Healthcare

Xcopri

Xcopri tab 12.5 mg + 25 mg

cenobamate

Packing/Price

(titration pack) 28's

MIMS Class

Anticonvulsants

ATC Classification

N03AX25 - cenobamate : Belongs to the class of other antiepileptics.

Xcopri tab 50 mg

cenobamate

Packing/Price

30's

MIMS Class

Anticonvulsants

ATC Classification

N03AX25 - cenobamate : Belongs to the class of other antiepileptics.

Distributed by Zuellig

Omjjara

Omjjara FC tab 100 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 150 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 200 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Marketed by GlaxoSmithKline

Omjjara

Omjjara FC tab 100 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 150 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.

Omjjara FC tab 200 mg

momelotinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.